about
Liver involvement in subjects with rheumatic diseaseUpdate on Autoimmune HepatitisAutoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future ResearchReview article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitisAssociation of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese populationrs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.Presence of antibodies against self human leukocyte antigen class II molecules in autoimmune hepatitis.Juvenile autoimmune hepatitis: Spectrum of the disease.Treatment of autoimmune hepatitis: a review of current and evolving therapies.Xenobiotic exposure and autoimmune hepatitisAutoimmune hepatitis: current challenges and future prospects.Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model.Epstein-barr virus as a trigger of autoimmune liver diseases.Immunomodulatory effects of black cohosh (Actaea racemosa) extract in female B6C3F1/N mice.Medullary thymic epithelial cell depletion leads to autoimmune hepatitis.Autoimmune liver disease: news and perspectives.Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapyPretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.Epidemiology and treatment of autoimmune hepatitis.Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitisPharmacological management of autoimmune hepatitis.Immunological diseases of the pancreatico-hepatobiliary system: update on etiopathogenesis and cross-sectional imaging findings.Autoimmune hepatitis from the paediatric perspective.Diagnosis and treatment of autoimmune hepatitis.Autoantibody-negative autoimmune hepatitis.Post-transplant liver biopsy and the immune response: lessons for the clinician.Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver DiseasesHLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT.HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice.Association of STAT4 and PTPN22 polymorphisms and their interactions with type-1 autoimmune hepatitis susceptibility in Chinese Han children.Assessment of the histopathological key features in autoimmune hepatitis.Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.Involvement of (IgG and IgM)-secreting B lymphocytes in severity of autoimmune hepatitis type 1.Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis.Herb-induced autoimmune-like hepatitis in C57BL/6J mice.Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.
P2860
Q22000839-D9927E9C-8B26-4129-BAD3-396E1BF610ECQ26781765-2B057BCF-2A89-4EB5-AC17-D0E60BB5F29DQ26786188-64E63CC4-FAD4-460C-B44F-7808A2E6B4F5Q26827599-66908FC3-D2F7-4CFB-AB17-9181A866D52BQ28535584-83C2446A-9E43-42F7-B2F0-41FE51D6EDE0Q33610813-9EB9C77C-FB44-44FA-83D2-7C93CB466473Q33843821-136CB13A-3FE6-4F83-9478-0F3E11701653Q33948215-6FA8750C-0D36-4FAB-8ECD-BD7462C6BD5CQ34149523-B266DEED-A714-47C2-8D57-97F09FA447BEQ34495354-2D4366CE-8B62-402D-B2AE-DCA16F2864BFQ34550808-C4B74E14-38CC-46F3-BB47-0B4374565F6FQ35016702-325777EC-8B71-4C03-A4FC-69F9325ADB49Q36010920-5EBCA2AE-A82D-41A3-947E-1C2BEEA0C085Q36935586-C0D952DE-723E-4CAB-9870-1BFC20010CA0Q37052887-6AF7445E-40DF-427A-8BB0-86ABB2ED76BCQ37058457-80F1FD91-A7FC-452D-BEE7-E5833F990BC0Q37075975-0E98FC47-85EA-4B61-9AB3-5405946E67EAQ37312637-FF4250A9-E263-4277-80F2-28E5578A79C6Q37356353-AA2B0B1D-2AA2-4F81-B5F9-E6D7EF852A45Q37682518-10FA28AF-7215-450B-B9E8-FA8C826DDF79Q37828507-E8E52350-BB3F-417C-B2F2-7F5B7B744227Q37877588-E6ECCB8E-AF49-4028-8A35-E1A9225F2B09Q37957350-30B73EB2-BEC1-4226-AD3B-86B7B24C943CQ37969669-3830D46F-7A58-4ECE-8BC2-CA7A10DA4EA8Q37970311-AC749275-4925-4431-8565-FA1EF9A94398Q38053173-8EDFD057-3100-4703-BFBD-D08432AB4689Q38238921-8B901470-B584-4BE3-A110-7158424675D1Q38496935-0F9C7B76-8372-4F80-9969-DBB95A126F0FQ38543052-955D8169-24F5-4F0B-A48A-194AF0CAD95FQ40373921-24EBB39C-906E-48CC-A985-B4038A26C07DQ41544167-182D23A0-BC18-4C01-979E-E2183B256267Q41551818-81A1849E-EEB5-42DC-B674-72D0B4FBD613Q41884870-42987715-A508-479D-980E-AAE0C2F0BAF6Q42185817-D6AF7354-1B1F-4765-B2CC-48BBF2746458Q42358509-C5BE4D68-0934-4465-B303-62D795E94085Q43486269-FFF7045D-8013-4004-8707-B00FEC7572B1Q45279226-D75ACBC7-125E-4AFB-ACAB-18E9823A507AQ47926558-15D8AFE0-6B2E-4B79-924A-751E493A5913Q47993022-40D37CF1-6F65-4088-B789-665E8FB6770BQ48218731-DA84321F-FDC8-4ECC-9865-75AB62DDF092
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aetiopathogenesis of autoimmune hepatitis.
@en
Aetiopathogenesis of autoimmune hepatitis.
@nl
type
label
Aetiopathogenesis of autoimmune hepatitis.
@en
Aetiopathogenesis of autoimmune hepatitis.
@nl
prefLabel
Aetiopathogenesis of autoimmune hepatitis.
@en
Aetiopathogenesis of autoimmune hepatitis.
@nl
P2093
P1476
Aetiopathogenesis of autoimmune hepatitis.
@en
P2093
Diego Vergani
Giorgina Mieli-Vergani
Maria Serena Longhi
P356
10.1016/J.JAUT.2009.08.010
P577
2009-09-18T00:00:00Z